Bio-Techne ( (TECH) ) has shared an update.
Bio-Techne Corporation faced a legal dispute regarding the expiration dates of stock options granted to its former CEO, Charles R. Kummeth. An administrative error led to a discrepancy in the expiration date of these options, resulting in arbitration. On February 26, 2025, an arbitrator ruled in favor of Mr. Kummeth, ordering the company to pay him approximately $35,978,000 for the options, along with interest and legal fees, due to the administrative error.
More about Bio-Techne
YTD Price Performance: -14.16%
Average Trading Volume: 1,152,487
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $9.76B
See more insights into TECH stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com